| Literature DB >> 31625836 |
Simone Silveira, Shollie M Falkenberg, Bryan S Kaplan, Beate Crossley, Julia F Ridpath, Fernando B Bauermann, Charles P Fossler, David A Dargatz, Rohana P Dassanayake, Amy L Vincent, Cláudio W Canal, John D Neill.
Abstract
Influenza D virus has been detected predominantly in cattle from several countries. In the United States, regional and state seropositive rates for influenza D have previously been reported, but little information exists to evaluate national seroprevalence. We performed a serosurveillance study with 1,992 bovine serum samples collected across the country in 2014 and 2015. We found a high overall seropositive rate of 77.5% nationally; regional rates varied from 47.7% to 84.6%. Samples from the Upper Midwest and Mountain West regions showed the highest seropositive rates. In addition, seropositive samples were found in 41 of the 42 states from which cattle originated, demonstrating that influenza D virus circulated widely in cattle during this period. The distribution of influenza D virus in cattle from the United States highlights the need for greater understanding about pathogenesis, epidemiology, and the implications for animal health.Entities:
Keywords: United States; bovine; bovine respiratory disease; epidemiology; hemagglutination inhibition assay; influenza; influenza D virus; viruses; zoonoses
Mesh:
Year: 2019 PMID: 31625836 PMCID: PMC6810200 DOI: 10.3201/eid2511.190253
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Number of samples collected from 42 states in study of influenza D virus in cattle, United States, 2014–2015. Asterisks (*) indicate states with 1 slaughter plant that contributed samples. Alaska, Hawaii, and states without numbers did not contribute samples.
Figure 2Maximum-likelihood phylogeny of the influenza D virus hemagglutinin-esterase fusion (HEF) gene constructed for study of influenza D virus in cattle, United States. Representative US strain D/bovine/Kansas/14-22/2012 (black dot), used as antigen in hemagglutination inhibition analysis, was aligned with reference strains from the Influenza Research Database (http://www.fludb.org) obtained on September 28, 2018. Bootstrap values >70% (1,000 replicates) are shown to the right of the nodes. Scale bar represents nucleotide substitutions per site.
Serosurveillance results for influenza D virus in cattle, by region and state, United States, 2014–2015*
| Region and state | No. samples | Seropositive rate, %† | GMT (range)‡ |
|---|---|---|---|
| Mountain West | |||
| Idaho | 187 | 87.2 | 230 (40–1,280) |
| Montana | 86 | 84.9 | 270 (40–1,280) |
| Colorado | 78 | 88.5 | 330 (40–1,280) |
| Utah | 29 | 79.3 | 240 (80–1,280) |
| Wyoming | 24 | 79.2 | 460 (80–1,280) |
| Arizona | 21 | 57.1 | 140 (40–1,280) |
| New Mexico | 16 | 93.8 | 210 (40–1,280) |
| Nevada | 8 | 75.0 | 250 (80–1,280) |
| Total | 449 | 84.6 | 260 (40–1,280) |
| Upper Midwest | |||
| Nebraska | 125 | 91.2 | 260 (40–1,280) |
| Iowa | 101 | 92.1 | 270 (40–1,280) |
| Kansas | 98 | 86.7 | 300 (40–1,280) |
| Missouri | 94 | 86.2 | 220 (40–1,280) |
| South Dakota | 87 | 90.8 | 300 (40–1,280) |
| Minnesota | 83 | 89.2 | 280 (40–1,280) |
| Wisconsin | 79 | 84.8 | 250 (40–1,280) |
| Ohio | 47 | 48.9 | 130 (40–640) |
| North Dakota | 41 | 56.1 | 400 (40–1,280) |
| Indiana | 27 | 37.0 | 120 (40–640) |
| Michigan | 19 | 63.2 | 190 (40–1,280) |
| Illinois | 6 | 83.3 | 160 (80–320) |
| Total | 807 | 84.0 | 260 (40–1,280) |
| South Central | |||
| Oklahoma | 102 | 79.4 | 230 (40–1,280) |
| Texas | 48 | 75.0 | 170 (40–1,280) |
| Total | 150 | 78.0 | 210 (40–1,280) |
| Pacific West | |||
| California | 166 | 77.7 | 190 (40–1,280) |
| Oregon | 42 | 76.2 | 300 (40–1,280) |
| Washington | 40 | 72.5 | 230 (40–1,280) |
| Total | 248 | 76.7 | 210 (40–1,280) |
| Southeast | |||
| Arkansas | 24 | 83.3 | 180 (40–640) |
| Virginia | 23 | 43.5 | 130 (40–640) |
| Kentucky | 22 | 68.2 | 310 (80–1,280) |
| Florida | 21 | 57.1 | 170 (40–1,280) |
| Alabama | 19 | 68.4 | 140 (40–1,280) |
| Tennessee | 10 | 50.0 | 240 (80–640) |
| West Virginia | 9 | 33.3 | 200 (80–640) |
| Louisiana | 7 | 42.9 | 160 (80–320) |
| Mississippi | 4 | 25.0 | 80 (80–80) |
| Georgia | 4 | 75.0 | 160 (80–320) |
| Total | 143 | 59.5 | 180 (40–1,280) |
| Northeast | |||
| Pennsylvania | 61 | 50.8 | 120 (40–1,280) |
| New York | 61 | 45.9 | 110 (40–1,280) |
| Vermont | 47 | 51.1 | 110 (40–640) |
| Connecticut | 11 | 0 | 0 |
| Maryland | 7 | 71.4 | 110 (40–1,280) |
| Massachusetts | 5 | 60.0 | 80 (80–80) |
| New Hampshire | 3 | 66.7 | 80 (80–80) |
| Total | 195 | 47.7 | 110 (40–1,280) |
*GMT, geometric mean titer. †Seropositive rate was calculated using those samples with hemagglutination inhibition titer ≥40. ‡GMT was calculated using those samples with HI titer ≥40. Lowest and highest titers were measured from those samples with HIT titer >40.